Skip to Content
Merck
CN

Key Documents

View All Documentation

11484281001

Roche

BM Blue POD Substrate, soluble

solution (ready-to-use), suitable for ELISA, pkg of 100 mL

Synonym(s):

3,3′,5,5′-Tetramethylbenzidine solution

Sign In to View Organizational & Contract Pricing.

Select a Size

Change View

About This Item

Empirical Formula (Hill Notation):
C16H20N2
CAS Number:
54827-17-7
Molecular Weight:
240.34
PubChem Substance ID:
329749453
UNSPSC Code:
12352204
Beilstein/REAXYS Number:
2808541
MDL number:
MFCD00007748
NACRES:
NA.54
Form:
solution (ready-to-use)
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

description

3,3′-5,5′-Tetramethylbenzidine (TMB)

form

solution (ready-to-use)

mol wt

Mr 240.35

packaging

pkg of 100 mL

manufacturer/tradename

Roche

technique(s)

ELISA: suitable

solubility

water: soluble

storage temp.

2-8°C

SMILES string

Cc1cc(cc(C)c1N)-c2cc(C)c(N)c(C)c2

InChI

1S/C16H20N2/c1-9-5-13(6-10(2)15(9)17)14-7-11(3)16(18)12(4)8-14/h5-8H,17-18H2,1-4H3

InChI key

UAIUNKRWKOVEES-UHFFFAOYSA-N

Application

BM Blue POD Substrate, soluble, is ideal for ELISA applications. It has been used in fluorescein-tagged exendin-4 binding assay.

Features and Benefits

Formula: C16H20N2
Color: blue; yellow after reaction is stopped
Evaluation: photometric (450 nm)

Physical form

Solution, ready-to-use

Analysis Note

Absorption: Identical to TMB absorption spectrum

Other Notes

For life science research only. Not for use in diagnostic procedures.

Storage Class

12 - Non Combustible Liquids

wgk

WGK 1

flash_point_f

No data available

flash_point_c

No data available

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
89654900
88093000
77408500
71788900
65060700

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Daming Zhou et al.
Nature structural & molecular biology, 27(10), 950-958 (2020-08-02)
The COVID-19 pandemic has had an unprecedented health and economic impact and there are currently no approved therapies. We have isolated an antibody, EY6A, from an individual convalescing from COVID-19 and have shown that it neutralizes SARS-CoV-2 and cross-reacts with
Sindhu Rajan et al.
Molecular metabolism, 4(4), 265-276 (2015-04-02)
Glucagon-like peptide 1 (GLP-1) enhances insulin secretion and protects β-cell mass. Diabetes therapies targeting the GLP-1 receptor (GLP-1R), expressed in numerous tissues, have diminished dose-response in patients with type 2 diabetes compared with healthy human controls. The aim of this
Jiandong Huo et al.
Nature structural & molecular biology, 27(9), 846-854 (2020-07-15)
The SARS-CoV-2 virus is more transmissible than previous coronaviruses and causes a more serious illness than influenza. The SARS-CoV-2 receptor binding domain (RBD) of the spike protein binds to the human angiotensin-converting enzyme 2 (ACE2) receptor as a prelude to
View All Related Papers

Global Trade Item Number

SKUGTIN
1148428100104061838254795